Australian Pharmaceutical Industries | API | Health care equipment & services
Performance | Valuation | Growth | Summary | Balance Sheet | Income Statement | Cash Flow
A$ in Million except per share figures. Fiscal year ends in August. Figures are consolidated and restated.
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | ||
Revenue |  | 3,251 | 3,556 | 3,717 | 3,438 | 3,233 | 3,203 | 3,353 | 3,463 | 3,846 | 4,061 |
Cost of revenue | | -3,203 | -3,491 | -3,649 | -3,369 | -3,159 | -3,128 | -3,524 | -3,369 | -3,734 | -3,949 |
Gross Profit | | 48 | 65 | 68 | 68 | 74 | 74 | -171 | 94 | 111 | 112 |
Depreciation | | 0 | -16 | -19 | -20 | -20 | -18 | -18 | -20 | -26 | -29 |
Provision | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other op inc/exp... | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating income | | 48 | 49 | 50 | 48 | 54 | 56 | -189 | 74 | 85 | 83 |
Interest expense | | -32 | -25 | -26 | -28 | -27 | -22 | -19 | -15 | -17 | -13 |
Other income/exp... | | 5 | 4 | 12 | 3 | 2 | 1 | 0.94 | 0.92 | 1 | 6 |
Profit before tax | | 21 | 27 | 36 | 24 | 29 | 35 | -208 | 59 | 69 | 76 |
Income tax & other ta... | | 6 | 9 | 13 | -7 | 13 | 11 | 6 | 16 | 17 | 24 |
Net income from c... | | 15 | 19 | 23 | 30 | 16 | 24 | -213 | 43 | 52 | 52 |
Extraordinary & disc... | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income | | 15 | 19 | 23 | -23 | 30 | 24 | -91 | 43 | 52 | 52 |
NI - Preferred Di... | | 15 | 19 | 23 | -23 | 30 | 24 | -91 | 43 | 52 | 52 |
Basic shares | | 257 | 257 | 441 | 488 | 488 | 488 | 488 | 488 | 489 | 490 |
Diluted Shares | | 257 | 257 | 441 | 488 | 488 | 488 | 488 | 496 | 489 | 494 |
EPS Basic | | 0.059 | 0.072 | 0.051 | -0.048 | 0.062 | 0.050 | -0.186 | 0.088 | 0.106 | 0.107 |
EPS Diluted | | 0.059 | 0.072 | 0.051 | -0.048 | 0.062 | 0.050 | -0.186 | 0.087 | 0.106 | 0.106 |